MORC3 and myositis disease: While we could not identify a definitive clinical profile of risk factors for calcinosis in our myositis patients, Fredi et al. considered anti-NXP-2 antibody as an independent predictive risk factor for calcinosis development (p = 0.024, OR 21.9, CI 95% = 1.5–319) [39].